drugset / Trial / NCT00919542
Ciclosporin in the Management of New Erythema Nodosum Leprosum
Phase 2
Completed
12 enrolled
London School of Hygiene and Tropical Medicine
Alert Hospital, Ethiopia · collabArmauer Hansen Research Institute, Ethiopia · collabHomes and Hospitals of St Giles · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Study 2A: Ciclosporin in the management of new Erythema Nodosum Leprosum Objective: A pilot (double blind controlled) study randomizing patients to treatment either with Ciclosporin or Prednisolone to assess the safety, tolerability and efficacy of Ciclosporin in the treatment of patients with new acute Type 2 reactions (ENL).
Timeline
- Start
- 2010-07
- Primary completion
- 2012-12
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 7.5 mg/kg | — |
| Comparator | Prednisolone | Other / unclassified | 40 mg | — |